Hemosphere Exceeds 4000 HeRO Grafts Sold – Rapid Therapy Adoption at Leading Best Practice Centers Aligns with Blood-Stream Infection (BSI) Reduction Initiatives
8/16/2011 10:20:46 AM
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Hemosphere, Inc., developer of the HeRO® Graft for hemodialysis access, announced that another sales record was achieved. Last week, Hemosphere sold the 4000th HeRO® Graft marking a new milestone in the company’s history.
comments powered by